Back
Rapt Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.00
Seasonality Move:
-10.23%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bullish and RAPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rapt Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.08 | Sell |
| 20-day SMA: | 32.41 | Buy |
| 50-day SMA: | 30.48 | Buy |
| 200-day SMA: | 15.73 | Buy |
| 8-day EMA: | 34.48 | Sell |
| 20-day EMA: | 33.02 | Buy |
| 50-day EMA: | 29.7 | Buy |
| 200-day EMA: | 21.78 | Buy |
Rapt Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.66 | Buy |
| Relative Strength Index (14 RSI): | 55.95 | Buy |
| Chaikin Money Flow: | 205819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 34.75) | Buy |
| Bollinger Bands (100): | (14.04 - 31.9) | Buy |
Rapt Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapt Therapeutics, Inc. Stock
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 34.03 while RAPT 8-day simple moving average is 35.08, which is a Sell signal.
-
The stock price of RAPT is 34.03 while Rapt Therapeutics, Inc. 20-day SMA is 32.41, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day simple moving average is 30.48 while RAPT share price is 34.03, making it a Buy technically.
-
RAPT stock price is 34.03 and Rapt Therapeutics, Inc. 200-day simple moving average is 15.73, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Sell
44
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a SellThe current Rapt Therapeutics, Inc. [RAPT] share price is $34.03. The Score for RAPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Rapt Therapeutics, Inc. Stock Info
Market Cap:
562.8M
Price in USD:
34.03
Share Volume:
338.3K
Rapt Therapeutics, Inc. 52-Week Range
52-Week High:
42.39
52-Week Low:
5.67
Sell
44
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Rapt Therapeutics, Inc. Share Price Forecast
-
What is the Rapt Therapeutics, Inc. stock price today?The Rapt Therapeutics, Inc. stock price is 34.03 USD today.
-
Will RAPT stock go up or go down?Rapt Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapt Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapt Therapeutics, Inc. is overvalued.
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 34.03 while RAPT 8-day exponential moving average is 34.48, which is a Sell signal.
-
The stock price of RAPT is 34.03 while Rapt Therapeutics, Inc. 20-day EMA is 33.02, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day exponential moving average is 29.70 while RAPT share price is 34.03, making it a Buy technically.
-
RAPT stock price is 34.03 and Rapt Therapeutics, Inc. 200-day simple moving average is 21.78, creating a Buy signal.
Fundamental Analysis of Rapt Therapeutics, Inc.
Is Rapt Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.75 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Rapt Therapeutics, Inc.
Should I short Rapt Therapeutics, Inc. stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 1.66, suggesting Rapt Therapeutics, Inc. is a Buy
-
Rapt Therapeutics, Inc. Relative Strength Index (RSI) is 55.95, which suggest Rapt Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapt Therapeutics, Inc. is (28.63 - 34.75), which suggest Rapt Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapt Therapeutics, Inc. is (14.04 - 31.9), which suggest Rapt Therapeutics, Inc. is a Buy
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.